Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021

Linyan Wang, Jianing Chen, Yunhang Shen, Grace Loy Ming Hooi, Shuohan Wu, Feng Xu, Pei Hao, Jianpeng Sheng, Tiansheng Zhu, Juan YeNeoplasia 2024 · DOI

Abstract

Despite global progress, regions with lower SDI face elevated Rb burden and mortality. Females exhibit higher burdens during infancy, necessitating further investigation. Effective Rb management in resource-limited areas requires international collaboration focused on health education, early diagnosis, and prenatal screening for high-risk families.
BibTeX
@inproceedings{wang2024incidence,
  author = {Linyan Wang and Jianing Chen and Yunhang Shen and Grace Loy Ming Hooi and Shuohan Wu and Feng Xu and Pei Hao and Jianpeng Sheng and Tiansheng Zhu and Juan Ye},
  title = {{Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021}},
  booktitle = {Neoplasia},
  year = {2024},
  doi = {10.1016/j.neo.2024.101107},
}

Loading related content...

Figure